Sol-Gel Technologies Ltd. (NASDAQ:SLGL) Short Interest Update

Sol-Gel Technologies Ltd. (NASDAQ:SLGL) saw a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 21,400 shares, a drop of 42.5% from the October 31st total of 37,200 shares. Based on an average daily trading volume, of 77,100 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.3% of the company’s shares are short sold.

Sol-Gel Technologies Stock Performance

Shares of NASDAQ SLGL remained flat at $0.58 during midday trading on Thursday. The company’s stock had a trading volume of 24,153 shares, compared to its average volume of 138,544. The firm has a market capitalization of $16.02 million, a price-to-earnings ratio of -1.69 and a beta of 1.60. Sol-Gel Technologies has a 12 month low of $0.33 and a 12 month high of $1.58. The business’s 50 day moving average price is $0.61 and its 200-day moving average price is $0.67.

Analyst Upgrades and Downgrades

Separately, Raymond James lowered shares of Sol-Gel Technologies from a “strong-buy” rating to an “outperform” rating and dropped their price objective for the company from $6.00 to $4.00 in a research note on Monday, August 19th.

About Sol-Gel Technologies

Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc, develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea.